+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-01-19Number of Pages: 93

Facial Injectables Market (Product - Botulinum Toxin, Hyaluronic Acid, Collagen, (Porcine/Bovine-based and Human-based), Particle & Polymer Fillers (PPF) (Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid, and Calcium Hydroxyapatite; Treatment - Facial Pain, Wrinkle Treatment, and Lip Augmentation; End User - Hospitals, Ambulatory Surgical Centers, Cosmetic Centers, Dermatology Clinics, and Physician Clinics) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Chapter 1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. North America facial injectables market: Market Snapshot
3.2. Market Share Analysis by country, 2015

Chapter 4. Market Overview
4.1. Product Overview
4.2. North America facial injectables market : Key Industry Events
4.3. North America Facial Injectables Market Size (US$ Mn) Forecast, 2014–2024
4.4. North America Facial Injectables Market Outlook
4.5. Porter’s Five Forces Analysis

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
       5.2.1. Enhanced longevity of the effects to augment demand for facial injectables
       5.2.2. Improving lifestyles and rising inclination toward minimally invasive surgeries 
       5.2.3. Growing global obsession with physical appearance and the desire to look young
       5.2.4. Escalating number of patients with various cosmetic skin problems such as scars, deep lines, and wrinkles 
       5.2.5. Increased rate of spending on esthetic procedures
5.3. Restraints
       5.3.1. Side-effects of available products limiting adoption
       5.3.2. Lack of appropriate reimbursement policies supporting cosmetic procedures
       5.3.3. High cost of treatment
5.4. Opportunities
       5.4.1. Product innovation and process development to overcome disadvantages of commercially available products
       5.4.2. New tools and smartphone applications that aid the purchasing process are likely to be created and used by consumers
5.5. Key Trends

Chapter 6. North America Facial Injectables Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. North America Facial Injectables Market Value Share Analysis, by Product Type
6.4. North America Facial Injectables Market Analysis, by Product Type 
       6.4.1. Botulinum Toxin
       6.4.2. Hyaluronic Acid
       6.4.3. Collagen
                6.4.3.1. Porcine/ Bovine-Based
                6.4.3.2. Human Based
       6.4.4. Particle & Polymer Fillers (PPF)
                6.4.4.1. Polymethylmethacrylate Beads (PMMA microspheres)
                6.4.4.2. Poly-L-Lactic Acid
                6.4.4.3. Calcium Hydroxyapatite 
6.5. North America Facial Injectables Market Attractiveness Analysis, by Product
6.6. Key Trends

Chapter 7. North America Facial Injectables Market Analysis, by Treatment Type
7.1. Key Findings
7.2. Introduction
7.3. North America Facial Injectables Market Value Share Analysis, by Treatment
7.4. North America Facial Injectables Market Analysis, by Treatment
       7.4.1. Facial Pain
       7.4.2. Wrinkle Treatment
       7.4.3. Lip Augmentation
       7.4.4. Others
7.5. North America Facial Injectables Market Attractiveness Analysis, by Treatment
7.6. Key Trends

Chapter 8. North America Facial Injectables Market Analysis, by End user
8.1. Key Findings
8.2. Introduction
8.3. North America Facial Injectables Market Value Share Analysis, by End User
8.4. North America Facial Injectables Market Analysis, by End User
       8.4.1. Hospitals
       8.4.2. Ambulatory Surgical Centers
       8.4.3. Cosmetic Centers
       8.4.4. Dermatology Clinics
       8.4.5. Physician Clinics 
8.5. North America Facial Injectables Market Attractiveness Analysis, by End User
8.6. Key Trends

Chapter 9. North America Facial Injectables Market Analysis, by Country
9.1. North America Facial Injectables Market Value Share Analysis, by Country 
9.2. North America Facial Injectables Market Forecast, by Country 
9.3. North America Facial Injectables Market Attractiveness Analysis, by Country
9.4. Market Trends 

Chapter 10. Company Profiles
10.1. North America Facial Injectables Market Share Analysis, by Company (2015)
10.2. Competition Matrix
10.3. Company Profiles
       10.3.1. Allergan plc.
                10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.1.2. Financial Overview
                10.3.1.3. Product Portfolio
                10.3.1.4. SWOT Analysis
                10.3.1.5. Strategic Overview
       10.3.2. Galderma S.A. (Nestle)
                10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.2.2. Financial Overview
                10.3.2.3. Product Portfolio
                10.3.2.4. SWOT Analysis
                10.3.2.5. Strategic Overview
       10.3.3. Merz Pharma & Co. KGaA
                10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.3.2. Financial Overview
                10.3.3.3. Product Portfolio
                10.3.3.4. SWOT Analysis
                10.3.3.5. Strategic Overview
       10.3.4. Prollenium Medical Technologies Inc.
                10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.4.2. Financial Overview
                10.3.4.3. Product Portfolio
                10.3.4.4. SWOT Analysis
                10.3.4.5. Strategic Overview
       10.3.5. Ipsen Group
                10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.5.2. Financial Overview
                10.3.5.3. Product Portfolio
                10.3.5.4. SWOT Analysis
                10.3.5.5. Strategic Overview
       10.3.6. Bloomage BioTechnology Corporation Limited 
                10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                10.3.6.2. Financial Overview
                10.3.6.3. Product Portfolio
                10.3.6.4. SWOT Analysis
                10.3.6.5. Strategic Overview

List of Figures

Figure 1: North America Facial Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
Figure 2: North America Facial Injectables Market Value Share, by Product Type, 2016 and 2024
Figure 3: North America Botulinum Toxin Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 4: North America Hyaluronic Acid Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 5: North America Collagen Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 6: North America Particles and Polymer Fillers (PPF) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 7: Facial Injectables Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 8: North America Facial Injectables Market Value Share, by Treatment Type, 2016 and 2024
Figure 9: North America Facial Pain Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: North America Wrinkle Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: North America Lip Augmentation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 12: North America Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 13: Facial Injectables Market Attractiveness Analysis, by Treatment Type, 2016–2024
Figure 14: North America Facial Injectables Market Value Share, by End-user, 2016 and 2024
Figure 15: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2014–2024
Figure 16: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2014–2024
Figure 17: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetic Centers, 2014–2024
Figure 18: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Dermatology Clinics, 2014–2024
Figure 19: North America Facial Injectables Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician Clinics, 2014–2024
Figure 20: North America Facial Injectables Market Attractiveness Analysis, by End-user, 2016–2024
Figure 21: North America Facial Injectables Market Value Share Analysis, by Country, 2016 and 2024
Figure 22: North America Facial Injectables Market Attractiveness Analysis, by Country, 2016–2024
Figure 23: North America Facial Injectables Market Share Analysis, by Company, 2016 (Estimated)

List of Tables

Table 1: North America Facial Injectables Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: North America Collagen Market Size (US$ Mn) Forecast, 2014–2024
Table 3: North America Particle & Polymer Fillers (PPF) Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 4: North America Facial Injectables Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 5: North America Facial Injectables Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 6: North America Facial Injectables Market Size (US$ Mn) Forecast, by Country, 2014–2024


 
 
Back To Top